Top Markets
Coin of the day
Shanghai Kinetic Medical Co., Ltd Shanghai Kinetic Medical Co., Ltd

Shanghai Kinetic Medical Co., Ltd

300326
Rank in Stocks #11910
Shanghai Kinetic Medical Co., Ltd operates as an international producer and... Shanghai Kinetic Medical Co., Ltd operates as an international producer and distributor of medical equipment, serving both the domestic Chinese market and global clients. Its extensive product portfolio caters to a range of medical specialties, including orthopedics, cardiovascular care, and sports medicine. Among its key offerings is the primom spinal fixation system, a sophisticated suite of instruments and implants engineered to address contemporary spinal deformities, degenerative conditions, and traumatic injuries. The company also provides kyphoplasty systems, vertebral osteotomes for creating precise cavities within vertebrae, and specialized bone cement delivery systems paired with injection guns. Furthermore, it supplies versatile tools for surgical insertion and pathway establishment, alongside kinect locking compression plate systems. The firm, established in 2005, maintains its headquarters in Shanghai, China.
Share Price
$0.89846608
Last synced: 2026-08-28
Market Cap
$644.21M
Change (1 day)
0.65%
Change (1 year)
10.08%
Country
CN
Trade Shanghai Kinetic Medical Co., Ltd (300326)

Category

Revenue for Shanghai Kinetic Medical Co., Ltd (300326)
Revenue in Aug 2026 TTM: 0
According to Shanghai Kinetic Medical Co., Ltd latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Shanghai Kinetic Medical Co., Ltd from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
$46.59B -
US
$25.84B -
US
$35.48B -
IE
$21.00B -
US
- -
DE